{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:41:48Z","timestamp":1792395708897,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"University of Toronto Division of Medical Oncology Strategic Innovation Fund"},{"name":"Soper Kidney Cancer Foundation"},{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12022-026-09930-2","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T05:17:25Z","timestamp":1787548645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Genomic Analysis in Hereditary Adrenal and Extra-Adrenal Paragangliomas"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7731-1670","authenticated-orcid":false,"given":"Helia","family":"Purnaghshband","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Tuzlali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalika Bhandari","family":"Deka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-201X","authenticated-orcid":false,"given":"Kirsten M.","family":"Farncombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1389-8027","authenticated-orcid":false,"given":"Brittany","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephenie D.","family":"Prokopec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8073-5888","authenticated-orcid":false,"given":"Trevor","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3528-6973","authenticated-orcid":false,"given":"Laura","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2147-8674","authenticated-orcid":false,"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"issue":"1","key":"9930_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/PAP.0000000000000365","volume":"30","author":"CC Juhlin","year":"2023","unstructured":"Juhlin CC, Mete O (2023) Advances in adrenal and extra-adrenal paraganglioma: practical synopsis for pathologists. Adv Anat Pathol 30(1):47-57. https:\/\/doi.org\/10.1097\/PAP.0000000000000365","journal-title":"Adv Anat Pathol"},{"issue":"10","key":"9930_CR2","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","volume":"23","author":"R Garcia-Carbonero","year":"2021","unstructured":"Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, et al (2021) Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin Transl Oncol 23(10):1995\u20132019. https:\/\/doi.org\/10.1007\/s12094-021-02622-9","journal-title":"Clin Transl Oncol"},{"key":"9930_CR3","unstructured":"Pacak K, Tella SH, Iyer AG (2000) Pheochromocytoma and paraganglioma. [Updated 2025 Jul 21]. In: Feingold KR, Adler RA, Ahmed SF, et al. editors. Endotext [Internet]. South Dartmouth (MA): MDText.com. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK481899\/"},{"issue":"3","key":"9930_CR4","doi-asserted-by":"publisher","DOI":"10.1530\/JME-22-0167","volume":"70","author":"A Casc\u00f3n","year":"2023","unstructured":"Casc\u00f3n A, Calsina B, Monteagudo M, et al (2023) Genetic bases of pheochromocytoma and paraganglioma. J Mol Endocrinol 70(3):e220167. https:\/\/doi.org\/10.1530\/JME-22-0167","journal-title":"J Mol Endocrinol"},{"issue":"9","key":"9930_CR5","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","volume":"23","author":"LJ Castro-Vega","year":"2014","unstructured":"Castro-Vega LJ, Buffet A, De Cubas AA, et al (2014) Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet 23(9):2440\u20132446. https:\/\/doi.org\/10.1093\/hmg\/ddt639","journal-title":"Hum Mol Genet"},{"issue":"2","key":"9930_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, et al (2017) Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31(2):181-193. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001","journal-title":"Cancer Cell"},{"issue":"5","key":"9930_CR7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1210\/jc.2008-2419","volume":"94","author":"M Mannelli","year":"2009","unstructured":"Mannelli M, Castellano M, Schiavi F, et al (2009) Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 94(5):1541\u20131547. https:\/\/doi.org\/10.1210\/jc.2008-2419","journal-title":"J Clin Endocrinol Metab"},{"issue":"R2","key":"9930_CR8","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1093\/hmg\/ddaa201","volume":"29","author":"R Casey","year":"2020","unstructured":"Casey R, Neumann HPH, Maher ER (2020) Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: Implications for precision medicine. Hum Mol Genet 29(R2):R128\u2013R137. https:\/\/doi.org\/10.1093\/hmg\/ddaa201","journal-title":"Hum Mol Genet"},{"issue":"4","key":"9930_CR9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/jc.2018-02411","volume":"104","author":"A Buffet","year":"2019","unstructured":"Buffet A, Ben Aim LN, Leboulleux S, et al (2019) Positive impact of genetic test on the management and outcome of patients with paraganglioma and\/or pheochromocytoma. J Clin Endocrinol Metab 104(4):1109\u20131118. https:\/\/doi.org\/10.1210\/jc.2018-02411","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9930_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.BEEM.2020.101416","volume":"34","author":"A Buffet","year":"2020","unstructured":"Buffet A, Burnichon N, Favier J, Gimenez-Roqueplo AP (2020) An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab 34(2):101416. https:\/\/doi.org\/10.1016\/J.BEEM.2020.101416","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"9930_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1210\/jc.2017-01762","volume":"103","author":"K Van Der Tuin","year":"2018","unstructured":"Van Der Tuin K, Mensenkamp AR, Tops CMJ, et al (2018) Clinical aspects of SDHA-related pheochromocytoma and paraganglioma: A nationwide study. J Clin Endocrinol Metab 103(2):438\u2013445. https:\/\/doi.org\/10.1210\/jc.2017-01762","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9930_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/ERC-19-0024","volume":"26","author":"J Crona","year":"2019","unstructured":"Crona J, Lamarca A, Ghosal S, et al (2019) Genotype-phenotype correlations in pheochromocytoma and paraganglioma: A systematic review and individual patient meta-analysis. Endocr Relat Cancer 26(5):539\u2013550. https:\/\/doi.org\/10.1530\/ERC-19-0024","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"9930_CR13","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","volume":"18","author":"N Burnichon","year":"2012","unstructured":"Burnichon N, Casc\u00f3n A, Schiavi F, et al (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res 18(10):2828\u20132837. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0160","journal-title":"Clin Cancer Res"},{"issue":"7","key":"9930_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-M\u00e9ndez","year":"2011","unstructured":"Comino-M\u00e9ndez I, Gracia-Azn\u00e1rez FJ, Schiavi F, et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43(7):663\u2013667. https:\/\/doi.org\/10.1038\/ng.861","journal-title":"Nat Genet"},{"issue":"2","key":"9930_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PLM Dahia","year":"2014","unstructured":"Dahia PLM (2014) Pheochromocytoma and paraganglioma pathogenesis: Learning from genetic heterogeneity. Nat Rev Cancer 14(2):108\u2013119. https:\/\/doi.org\/10.1038\/nrc3648","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"9930_CR16","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1001\/jama.2010.1830","volume":"304","author":"L Yao","year":"2010","unstructured":"Yao L, Schiavi F, Cascon A, et al (2010) Spectrum and prevalence of FP\/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA 304(23):2611\u20132619. https:\/\/doi.org\/10.1001\/jama.2010.1830","journal-title":"JAMA"},{"issue":"10","key":"9930_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","volume":"52","author":"M Curr\u00e1s-Freixes","year":"2015","unstructured":"Curr\u00e1s-Freixes M, Inglada-P\u00e9rez L, Mancikova V, et al (2015) Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients. J Med Genet 52(10):647\u2013656. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103218","journal-title":"J Med Genet"},{"issue":"7624","key":"9930_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/538161a","volume":"538","author":"AB Popejoy","year":"2016","unstructured":"Popejoy AB, Fullerton SM (2016) Genomics is failing on diversity. Nature 538(7624):161-164. https:\/\/doi.org\/10.1038\/538161a","journal-title":"Nature"},{"issue":"1","key":"9930_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","volume":"177","author":"G Sirugo","year":"2019","unstructured":"Sirugo G, Williams SM, Tishkoff SA (2019) The missing diversity in human genetic studies. Cell 177(1):26\u201331. https:\/\/doi.org\/10.1016\/j.cell.2019.02.048","journal-title":"Cell"},{"issue":"5","key":"9930_CR20","doi-asserted-by":"publisher","first-page":"e1917","DOI":"10.1210\/clinem\/dgac014","volume":"107","author":"C Horton","year":"2022","unstructured":"Horton C, Laduca H, Deckman A, et al (2022) Universal germline panel testing for individuals with pheochromocytoma and paraganglioma produces high diagnostic yield. J Clin Endocrinol Metab 107(5):e1917\u2013e1923. https:\/\/doi.org\/10.1210\/clinem\/dgac014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9930_CR21","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1097\/PAS.0000000000000534","volume":"39","author":"A Giubellino","year":"2015","unstructured":"Giubellino A, Lara K, Martucci V, et al (2015) Urinary bladder paragangliomas: how immunohistochemistry can assist to identify patients with SDHB germline and somatic mutations. Am J Surg Pathol 39(11):1488\u20131492. https:\/\/doi.org\/10.1097\/PAS.0000000000000534","journal-title":"Am J Surg Pathol"},{"key":"9930_CR22","doi-asserted-by":"publisher","first-page":"1121397","DOI":"10.3389\/fendo.2023.1121397","volume":"14","author":"T Su","year":"2023","unstructured":"Su T, Yang Y, Jiang L, et al (2023) SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis. Front Endocrinol (Lausanne) 14:1121397. https:\/\/doi.org\/10.3389\/fendo.2023.1121397","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"9930_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBCAN.2024.189141","volume":"1879","author":"A Casc\u00f3n","year":"2024","unstructured":"Casc\u00f3n A, Robledo M (2024) Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma. Biochim Biophys Acta (BBA) - Rev Cancer 1879(5):189141. https:\/\/doi.org\/10.1016\/J.BBCAN.2024.189141","journal-title":"Cancer"},{"issue":"2","key":"9930_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/jmg-2024-110265","volume":"62","author":"P Dremsek","year":"2025","unstructured":"Dremsek P, Schachner A, Reischer T, et al (2025) Retrospective study on the utility of optical genome mapping as a follow-up method in genetic diagnostics. J Med Genet 62(2):89-96. https:\/\/doi.org\/10.1136\/jmg-2024-110265","journal-title":"J Med Genet"},{"issue":"5","key":"9930_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"D1","key":"9930_CR26","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, et al (2014) ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42(D1):D980-985. https:\/\/doi.org\/10.1093\/nar\/gkt1113","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"9930_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/humu.21136","volume":"31","author":"CJ Ricketts","year":"2010","unstructured":"Ricketts CJ, Forman JR, Rattenberry E, et al (2010) Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31(1):41-51. https:\/\/doi.org\/10.1002\/humu.21136","journal-title":"Hum Mutat"},{"issue":"1-2","key":"9930_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2012.01.009","volume":"205","author":"L Fishbein","year":"2012","unstructured":"Fishbein L, Nathanson KL (2012) Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet 205(1-2):1-11. https:\/\/doi.org\/10.1016\/j.cancergen.2012.01.009","journal-title":"Cancer Genet"},{"issue":"1","key":"9930_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2796.2004.01425.x","volume":"257","author":"K Pacak","year":"2005","unstructured":"Pacak K, Ilias I, Adams KT, Eisenhofer G (2005) Biochemical diagnosis, localization and management of pheochromocytoma: Focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour. J Intern Med 257(1):60\u201368. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01425.x","journal-title":"J Intern Med"},{"issue":"6","key":"9930_CR30","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1210\/jc.2009-0354","volume":"94","author":"CC Boedeker","year":"2009","unstructured":"Boedeker CC, Erlic Z, Richard S, et al (2009) Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 94(6):1938\u20131944. https:\/\/doi.org\/10.1210\/jc.2009-0354","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9930_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/nejmoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497\u2013506. https:\/\/doi.org\/10.1056\/nejmoa1400382","journal-title":"N Engl J Med"},{"issue":"10","key":"9930_CR32","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","volume":"21","author":"MB Daly","year":"2023","unstructured":"Daly MB, Pal T, Maxwell KN, et al (2023) NCCN Guidelines\u00ae insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024. J Natl Compr Canc Netw 21(10):1000-1010. https:\/\/doi.org\/10.6004\/jnccn.2023.0051","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"9930_CR33","doi-asserted-by":"publisher","first-page":"bbac221","DOI":"10.1093\/bib\/bbac221","volume":"23","author":"V Sarwal","year":"2022","unstructured":"Sarwal V, Niehus S, Ayyala R, et al (2022) A comprehensive benchmarking of WGS-based deletion structural variant callers. Brief Bioinform 23(4):bbac221. https:\/\/doi.org\/10.1093\/bib\/bbac221","journal-title":"Brief Bioinform"},{"issue":"11","key":"9930_CR34","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.annonc.2022.07.008","volume":"33","author":"A Jahn","year":"2022","unstructured":"Jahn A, Rump A, Widmann TJ, et al (2022) Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers. Ann Oncol 33(11):1186\u20131199. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.008","journal-title":"Ann Oncol"},{"issue":"4","key":"9930_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10689-019-00144-6","volume":"18","author":"MK Ndugga-Kabuye","year":"2019","unstructured":"Ndugga-Kabuye MK, Issaka RB (2019) Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European. Fam Cancer 18(4):465\u2013469. https:\/\/doi.org\/10.1007\/s10689-019-00144-6","journal-title":"Fam Cancer"},{"key":"9930_CR36","doi-asserted-by":"publisher","unstructured":"Garcia AB de M, Viola GD, Corr\u00eaa B da S, et al (2024) An overview of actionable and potentially actionable TSC1 and TSC2 germline variants in an online database. Genet Mol Biol 46(3 Suppl 1):e20230132. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2023-0132","DOI":"10.1590\/1678-4685-GMB-2023-0132"},{"issue":"12","key":"9930_CR37","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1128\/mcb.00289-08","volume":"28","author":"J Huang","year":"2008","unstructured":"Huang J, Dibble CC, Matsuzaki M, Manning BD (2008) The TSC1-TSC2 complex is required for proper activation of MTOR complex 2. Mol Cell Biol 28(12):4104\u20134115. https:\/\/doi.org\/10.1128\/mcb.00289-08","journal-title":"Mol Cell Biol"},{"key":"9930_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.678869","volume":"12","author":"B Chevalier","year":"2021","unstructured":"Chevalier B, Dupuis H, Jannin A, et al (2021) Phakomatoses and endocrine gland tumors: noteworthy and (not so) rare associations. Front Endocrinol (Lausanne) 12:678869. https:\/\/doi.org\/10.3389\/fendo.2021.678869","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"9930_CR39","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/s41436-018-0397-6","volume":"21","author":"W Mu","year":"2019","unstructured":"Mu W, Li B, Wu S, et al (2019) Detection of structural variation using target captured next-generation sequencing data for genetic diagnostic testing. Genet Med 21(7):1603\u20131610. https:\/\/doi.org\/10.1038\/s41436-018-0397-6","journal-title":"Genet Med"},{"issue":"23","key":"9930_CR40","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.3390\/cancers14235875","volume":"14","author":"E Forkosh","year":"2022","unstructured":"Forkosh E, Bergel M, Hatchell KE, et al (2022) Ashkenazi Jewish and other white APC I1307K carriers are at higher risk for multiple cancers. Cancers (Basel) 14(23):5875. https:\/\/doi.org\/10.3390\/cancers14235875","journal-title":"Cancers (Basel)"},{"issue":"2","key":"9930_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs ER, Andersen EF, Cherry AM, et al (2020) Technical standards for the interpretation and reporting of constitutional copy-number variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med 22(2):245\u2013257. https:\/\/doi.org\/10.1038\/s41436-019-0686-8","journal-title":"Genet Med"},{"issue":"12","key":"9930_CR42","doi-asserted-by":"publisher","first-page":"bvab163","DOI":"10.1210\/jendso\/bvab163","volume":"5","author":"S Miyamoto","year":"2021","unstructured":"Miyamoto S, Yoshida Y, Ozeki Y, et al (2021) Dopamine-secreting pheochromocytoma and paraganglioma. J Endocr Soc 5(12):bvab163. https:\/\/doi.org\/10.1210\/jendso\/bvab163","journal-title":"J Endocr Soc"},{"issue":"9","key":"9930_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.6004\/jnccn.2025.7035","volume":"23","author":"V Sukrithan","year":"2025","unstructured":"Sukrithan V, Boateng I, Liyanarachchi S, et al (2025) Whole-exome sequencing reveals high prevalence of germline alterations in neuroendocrine neoplasms. J Natl Compr Canc Netw 23(9):379\u2013384. https:\/\/doi.org\/10.6004\/jnccn.2025.7035","journal-title":"J Natl Compr Canc Netw"}],"updated-by":[{"DOI":"10.1007\/s12022-026-09937-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000}}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-026-09930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-026-09930-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-026-09930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:00:41Z","timestamp":1792393241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-026-09930-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9930"],"URL":"https:\/\/doi.org\/10.1007\/s12022-026-09930-2","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"21 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12022-026-09937-9","URL":"https:\/\/doi.org\/10.1007\/s12022-026-09937-9","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the University Health Network Research Ethics Board (REB ID: 21-5031) and was conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to publication.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Ozgur Mete is the Editor-in-Chief of Endocrine Pathology. This article was handled by an independent senior Editor and peer reviewed as per the journal standards. The remaining authors declare no competing financial or non-financial interests relevant to this work.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This entire manuscript was authored by humans. ChatGPT (OpenAI Ireland Ltd.) and Claude (Anthropic) were only used for AI assisted copy editing purposes to improve readability and style in selected sections. The authors reviewed and edited all output and take full responsibility for the content of the publication.","order":4,"name":"Ethics","label":"Generative AI and AI-Assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"35"}}